Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature ...

A UConn professor and researcher who 28 years ago discovered a gene for a protein that limits human muscle growth is closer than ever to having that work play a significant role in treating those with ...

Over time, SMA eventually leads to the weakening and wasting away of the muscles. It's estimated to affect around 1 in every 10,000 live births. Related: The exceptionally rare disease that causes ...

Spinal muscular atrophy type 1 is a genetic disorder that typically appears within the first six months of life, causing ...

A study based on a survey of 50 adults linked poorer quality sleep with more depressive symptoms and respiratory issues in ...

The author highlights the real-life impacts on the residents of Knoxville and East Tennessee from Trump administration cuts ...

The classification of spinal muscular atrophy (SMA) subtypes, the influence of SMN2 gene copies on disease severity, treatment effects on disease progression, age-related differences, long-term ...

Evrysdi is the only non-invasive disease-modifying treatment for SMA. The 5 mg Evrysdi tablet can either be swallowed whole or dispersed in water. “Evrysdi has robust potential to modify the SMA ...

SMA can cause sleep challenges, but certain strategies can help improve your sleep quality and overall health.

SMA patients and advocacy groups have called for urgent action to make life-saving treatments more accessible. The cost of ...

Spinal Muscular Atrophy (SMA) is a genetic and hereditary disease characterized by a loss of muscle strength due to the ...